Research Projects All Projects
Projects

Quick links

Precision medicine test for the therapeutic decisions and monitoring of treatment response in breast cancer

 

 

Project Title: „ Precision medicine test for the therapeutic decisions and monitoring of treatment response in breast cancer

Funding: European Regional Development Fund (ERDF), Measure 1.2.1. Specific support goal "To Increase the Private Sector Investments R&D"; measure 1.2.1.2. "Support for Improvement of Technology Transfer System" “Industry‑Driven Research”

Project Nr.: KC-PI-2017/23 

 

Technical and economic feasibility study and the development of commercialisation strategy period 19 th July 2017 – 23 th July 2018

Technical and economic feasibility study and the development of commercialisation strategy costs: 27 777,77 EUR

Principle Investigator: Dr. biol. A. Linē

 

The commercialisation strategy will contain a detailed plan for bringing the precision medicine tool described in this project to the market.

The commercialisation measures will consist of industrial research and experimental development aiming to demonstrate the clinical validity of the proposed precision medicine approach.         

The main aim of the current project is to develop a precision medicine test for molecular profiling of breast cancer that helps to choose the best treatment option for each patient and a personalised liquid biopsy for monitoring the treatment response and early detection of recurrence.

The main objective of this project is to demonstrate the clinical validity of such a precision medicine approach in breast cancer patients. After the end of this project, these tests will be registered as laboratory developed tests and offered as molecular diagnostics services that can help in a clinical decision making.

This project will provide an opportunity to create a new in vitro diagnostics service that will be the first of its kind in Latvia and may turn out to be internationally competitive.

 

Published 24.07.2017.

 

19.07.2017.-19.10.2017.

In the period from 19.07.2017.until 19.10.2017. Within the framework of the project, a market research was conducted on potential bidders for the procurement of development of a commercialization strategy.

The procurement regulations for procurement "Development of a commercial strategy" were prepared. The purpose of the service is to define the steps to develop a product or technology from conception to market introduction, and also to analyze the choice of a more advantageous solution between assigning the right to use industrial property to another person (licensing agreement, patent sale) or creating a new business on a scientific basis, and make recommendation what information should be prepared to get potential licensees or investment funds attention and offer them the technology. The above-mentioned procurement was announced on the website of the Procurement Monitoring Bureau on 12.10.2017.

Published 19.10.2017.

 

19.10.2017-18.01.2018

The procurement resulted in concluding a contract with “Enixus Baltija” for the development of Commercialisation Strategy. Several meetings between the contractor and BMC team were organised to discuss the technological aspects, potential markets, IPRs, choice of commercialisation strategy and the next steps to the market. The contractor, in a close collaboration with the BMC team, is working on the development of the Commercialisation Strategy. In parallel, we were working on the development of the technical-economic feasibility study.

Published 31.01.2018.

 

19.01.2018-18.04.2018

In reporting period was agreed project 1st period extension whit Latvian Investment and Development Agency to ensure quality of a Technical feasibility and commercialisation strategy development.  Was prepared procurement rules for “Technical feasibility and commercialisation strategy development service” as part of which is planned to purchase individual previously undrafted Technical feasibility study section as well as Commercialisation strategies for project. The above procurement was announced in Procurement Monitoring Bureau web page in 20.03.2018.

The offer was submitted and as the winner in the procurement was recognized KPMG Baltics Ltd

 Published 18.04.2018.

 

19.04.2018-18.07.2018

During the reporting period continue work to the development of the Technically Economic feasibility study and the Commercialisation strategy with “KPMG Baltics”.

Published 18.07.2018.




Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".